Skip to main content
Back

Disorders Associated with the Immune System: Hypersensitivity, Autoimmunity, Transplantation, Cancer, and Immunodeficiencies

Study Guide - Smart Notes

Tailored notes based on your materials, expanded with key definitions, examples, and context.

Disorders Associated with the Immune System

Hypersensitivity

Hypersensitivity refers to an antigenic response that results in undesirable effects, occurring when an individual is sensitized by previous exposure to an antigen (allergen). There are four types of hypersensitivity reactions, each with distinct mechanisms and clinical manifestations.

  • Type I (Anaphylactic) Reactions: - Occur within minutes after re-exposure to an antigen. - IgE antibodies bind to mast cells and basophils, leading to degranulation and release of mediators such as histamine, leukotrienes, and prostaglandins. - Systemic anaphylaxis can cause shock and death; treated with epinephrine. - Localized anaphylaxis affects specific regions (e.g., hay fever, asthma, food allergies). - Allergy skin tests and desensitization (producing IgG blocking antibodies) are used for diagnosis and prevention.

Diagram of IgE binding to Fc receptors on mast cells Diagram of mast cell degranulation and mediator release SEM image of degranulated mast cell with histamine granules

  • Type II (Cytotoxic) Reactions: - Involve activation of complement by IgG or IgM antibodies bound to antigenic cells, causing cell lysis or damage. - ABO and Rh blood group systems are classic examples. - Hemolytic disease of the newborn (HDNB) occurs when an Rh-negative mother produces anti-Rh antibodies against an Rh-positive fetus. - Drug-induced cytotoxic reactions include immune thrombocytopenic purpura, agranulocytosis, and hemolytic anemia.

Diagram of hemolytic disease of the newborn Diagram of drug-induced immune thrombocytopenic purpura

  • Type III (Immune Complex) Reactions: - Antibodies react with soluble antigens, forming immune complexes that lodge in basement membranes and activate complement, causing inflammation. - Examples include Arthus reaction and serum sickness.

Diagram of immune complex-mediated hypersensitivity

  • Type IV (Delayed Cell-Mediated) Reactions: - Mediated by T cells; delayed hypersensitivity develops after a day or more. - Examples include tuberculosis skin test and allergic contact dermatitis (e.g., poison ivy, cosmetics, metals, latex).

Diagram of allergic contact dermatitis to poison ivy Image of allergic contact dermatitis on skin

The Hygiene Hypothesis

The hygiene hypothesis suggests that limiting exposure to pathogens may lower immune tolerance and the ability to cope with harmless antigens. Dysbiosis, or imbalance of microbiota, can lead to adverse effects such as inflammatory bowel diseases (IBDs) and allergies. Treatments include fecal transplants and whipworm therapy for Crohn's disease.

Endoscope views of healthy and inflamed colon in Crohn's disease Fecal transplant capsules and whipworm egg used for Crohn's disease

Autoimmune Diseases

Autoimmune diseases occur when the immune system responds to self-antigens, causing organ damage. Self-tolerance is normally maintained by clonal deletion of self-reactive T cells in the thymus. Loss of self-tolerance leads to autoimmunity, which can be cytotoxic, immune complex, or cell-mediated.

  • Cytotoxic Autoimmune Reactions: - Multiple sclerosis: Autoantibodies, T cells, and macrophages attack myelin sheath of nerves.

  • Immune Complex Autoimmune Reactions: - Systemic lupus erythematosus: Autoantibodies against DNA form immune complexes in kidneys. - Rheumatoid arthritis: Immune complexes deposit in joints, causing chronic inflammation.

  • Cell-Mediated Autoimmune Reactions: - Type 1 diabetes: T cell destruction of insulin-secreting cells. - Psoriasis: T cells induce keratinocyte growth.

Reactions to Transplantation

Transplant rejection is mediated by T cells, macrophages, and complement-fixing antibodies. The HLA complex (human MHC) is crucial for tissue matching. Privileged sites (e.g., cornea) and privileged tissues (e.g., decellularized pig heart valves) do not provoke immune responses. Stem cells, both embryonic and adult, are used for tissue regeneration.

Diagram of tissue typing for HLA antigens Diagram of embryonic stem cell derivation and differentiation

  • Types of Grafts: - Autograft: One's own tissue - Isograft: Identical twin's tissue - Allograft: Tissue from another person - Xenotransplantation: Nonhuman tissue (e.g., "GalSafe" pigs)

  • Immunosuppression: - Drugs such as cyclosporine, tacrolimus, sirolimus, mycophenolate, and basiliximab suppress immune responses to prevent rejection.

The Immune System and Cancer

Cancer cells express tumor-associated antigens and are targeted by cytotoxic T lymphocytes (CTLs), activated macrophages, and natural killer (NK) cells. However, cancer cells may evade immune detection by lacking antigenic epitopes, reproducing rapidly, or becoming invisible to the immune system. Immunotherapy includes bacterial endotoxins, vaccines (e.g., HPV, hepatitis B), and monoclonal antibodies.

Immunodeficiencies

Immunodeficiencies are characterized by insufficient immune responses. They may be congenital (genetic defects, e.g., DiGeorge syndrome, SCID) or acquired (e.g., AIDS, caused by HIV infection). AIDS is diagnosed by antibody tests and nucleic acid amplification tests (NAATs), and treated with antiretroviral drugs targeting reverse transcriptase, integrase, and protease enzymes.

Acquired Immunodeficiency Syndrome (AIDS)

HIV infects CD4+ T cells, leading to progressive immune failure. The virus attaches via gp120 to CD4 and CCR5/CXCR4 coreceptors, enters the cell, and integrates its DNA into the host genome. HIV evades immunity by latency, cell-cell fusion, and rapid mutation. The disease progresses through three phases: asymptomatic, symptomatic, and AIDS (CD4+ T cell count < 200/μL). Transmission occurs via blood, semen, breast milk, and other routes. Prevention and treatment include behavioral, biomedical, and structural interventions, as well as antiretroviral therapy.

Summary Table: Types of Hypersensitivity

Type of Reaction

Time Before Clinical Signs

Characteristics

Examples

Type I (Anaphylactic)

< 30 min

IgE binds to mast cells/basophils; allergen binding causes degranulation and release of mediators

Anaphylactic shock, hay fever, asthma

Type II (Cytotoxic)

5-12 hours

IgM/IgG bind to target cell; complement destroys cell

Transfusion reactions, Rh incompatibility

Type III (Immune Complex)

3-8 hours

Antibody-antigen complexes cause inflammation

Arthus reaction, serum sickness, rheumatoid arthritis

Type IV (Delayed Cell-Mediated)

24-48 hours

Antigens activate CTLs that kill target cell

Transplant rejection, contact dermatitis, tuberculosis

Summary Table: Selected Autoimmune Disorders

Autoimmune Disease

Possible Cause

Chronic fatigue syndrome

Antibodies attach to acetylcholine receptors

Rheumatoid arthritis

Immune complexes accumulate in joints

Systemic lupus erythematosus

Immune complexes against DNA

Multiple sclerosis

T cells/macrophages attack myelin sheath

Type 1 diabetes

T cells destroy insulin-secreting cells

Guillain-Barré syndrome

T cells cause destruction of myelin sheath

Psoriasis

T cells induce keratinocyte growth

Graves' disease

Antibodies stimulate thyroid hormone production

Myasthenia gravis

Antibodies block acetylcholine receptors

Crohn's disease

Antibacterial antibodies react with intestinal mucosa

Inflammatory bowel disease

Antibacterial antibodies react with intestinal mucosa

Summary Table: Selected Immunodeficiencies

Disease

Cells Affected

Comments

AIDS

CD4+ T cells

Allows opportunistic infections; caused by HIV

Selective IgA immunodeficiency

B, T cells

Frequent mucosal infections

Common variable hypogammaglobulinemia

B, T cells

Frequent viral/bacterial infections

Reticular dysgenesis

B, T, stem cells

Usually fatal in infancy

SCID

B, T, stem cells

Severe infections; treated with bone marrow transplant

Thymic aplasia (DiGeorge syndrome)

T cells

Absence of cell-mediated immunity; fatal in infancy

Wiskott-Aldrich syndrome

B, T cells

Frequent infections; inherited on X chromosome

X-linked infantile (Bruton’s) agammaglobulinemia

B cells

Frequent bacterial infections; inherited on X chromosome

Summary Table: HIV Life Cycle Drug Targets

Drug Class

Target

Examples

Fusion/Entry Inhibitors

gp41, CCR5

Enfuvirtide, Maraviroc

Reverse Transcriptase Inhibitors

Reverse transcriptase

Tenofovir, Emtricitabine

Integrase Inhibitors

Integrase

Raltegravir, Dolutegravir, Elvitegravir

Protease Inhibitors

Protease

Atazanavir, Indinavir, Saquinavir

Diagram of drugs that inhibit HIV life cycle

Summary Table: Diseases Associated with AIDS

Pathogen/Disease

Disease Description

Cryptosporidium hominis

Persistent diarrhea

Toxoplasma gondii

Encephalitis

Cytomegalovirus (HHV-5)

Fever, encephalitis, blindness

Mycobacterium tuberculosis

Tuberculosis

Pneumocystis jirovecii

Life-threatening pneumonia

Kaposi’s sarcoma

Cancer of skin and blood vessels

Graph of HIV infection progression and CD4+ T cell count World map of HIV/AIDS prevalence by region

Key Terms and Concepts

  • Hypersensitivity: Immune response causing undesirable effects.

  • Autoimmunity: Loss of self-tolerance; immune response to self-antigens.

  • Immunodeficiency: Insufficient immune response; congenital or acquired.

  • HLA/MHC: Self-antigens important for tissue matching.

  • Antiretroviral Therapy: Drugs targeting HIV enzymes to prevent replication.

Important Equations

  • CD4+ T cell count diagnostic for AIDS: *Normal range: 500–1500/μL*

Additional info:

  • Stem cell therapy and tissue engineering are emerging fields for transplantation and regenerative medicine.

  • Hygiene hypothesis is supported by epidemiological studies comparing urban and rural populations.

Pearson Logo

Study Prep